Mark Brown
9Patents
3h-index
10Co-inventors
50Inventor score
Filing activity: Mar 1, 2001 → Feb 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10752691B2 | Anti-CD25 antibody agents | Chemistry; Metallurgy | 10 | Active |
| US10745485B2 | Anti-CD25 antibody agents | Chemistry; Metallurgy | 10 | Active |
| US10738125B2 | Anti-CD25 antibody agents | Chemistry; Metallurgy | 10 | Active |
| US7439025B2 | Antibodies binding a gamma carboxyglutamic acid displaying epitope | Chemistry; Metallurgy | 3 | Expired |
| US11787866B2 | Anti-CD25 antibody agents | Chemistry; Metallurgy | 0 | Active |
| US11802160B2 | Anti-CD25 antibody agents | Chemistry; Metallurgy | 0 | Active |
| US11802161B2 | Anti-CD25 for tumour specific cell depletion | Chemistry; Metallurgy | 0 | Active |
| US11814434B2 | Anti-CD25 for tumour specific cell depletion | Chemistry; Metallurgy | 0 | Active |
| US11697688B2 | Anti-CD25 for tumour specific cell depletion | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.